Recent blog posts
Herpes zoster Indication Strategy Report 2026: TLR9, Trials and Deals
Latest Hotspot
8 min read
Herpes zoster Indication Strategy Report 2026: TLR9, Trials and Deals
21 July 2026
Herpes zoster indication strategy report covering epidemiology, TLR9 biology, active trials, competition and deal signals using PatSnap MCP evidence.
Read →
Genital herpes Indication Strategy Report 2026: TLR9, Trials and Deals
Latest Hotspot
8 min read
Genital herpes Indication Strategy Report 2026: TLR9, Trials and Deals
21 July 2026
Genital herpes indication strategy report covering epidemiology, TLR9 biology, active trials, competition and deal signals using PatSnap MCP evidence.
Read →
Human metapneumovirus infection Indication Strategy Report 2026: RIG-I, Trials and Deals
Latest Hotspot
8 min read
Human metapneumovirus infection Indication Strategy Report 2026: RIG-I, Trials and Deals
21 July 2026
Human metapneumovirus infection indication strategy report covering epidemiology, RIG-I biology, active trials, competition and deal signals using PatSnap MCP...
Read →
Cytomegalovirus infection Indication Strategy Report 2026: TLR9, Trials and Deals
Latest Hotspot
8 min read
Cytomegalovirus infection Indication Strategy Report 2026: TLR9, Trials and Deals
21 July 2026
Cytomegalovirus infection indication strategy report covering epidemiology, TLR9 biology, active trials, competition and deal signals using PatSnap MCP evidence.
Read →
Mpox Indication Strategy Report 2026: STING, Trials and Deals
Latest Hotspot
8 min read
Mpox Indication Strategy Report 2026: STING, Trials and Deals
21 July 2026
Mpox indication strategy report covering epidemiology, STING biology, active trials, competition and deal signals using PatSnap MCP evidence.
Read →
Zika virus disease Indication Strategy Report 2026: AXL, Trials and Whitespace
Latest Hotspot
8 min read
Zika virus disease Indication Strategy Report 2026: AXL, Trials and Whitespace
21 July 2026
Zika virus disease indication strategy report covering epidemiology, AXL biology, active trials, competition and deal signals using PatSnap MCP evidence.
Read →
Chikungunya Indication Strategy Report 2026: MXRA8, Trials and Deals
Latest Hotspot
8 min read
Chikungunya Indication Strategy Report 2026: MXRA8, Trials and Deals
21 July 2026
Chikungunya indication strategy report covering epidemiology, MXRA8 biology, active trials, competition and deal signals using PatSnap MCP evidence.
Read →
Malaria Indication Strategy Report 2026: DHODH, Trials and Deals
Latest Hotspot
8 min read
Malaria Indication Strategy Report 2026: DHODH, Trials and Deals
21 July 2026
Malaria indication strategy report covering epidemiology, DHODH biology, active trials, competition and deal signals using PatSnap MCP evidence.
Read →
Anorexia nervosa Indication Strategy Report 2026: MC4R, Trials and Deals
Latest Hotspot
8 min read
Anorexia nervosa Indication Strategy Report 2026: MC4R, Trials and Deals
21 July 2026
Anorexia nervosa indication strategy report covering epidemiology, MC4R biology, active trials, competition and deal signals using PatSnap MCP evidence.
Read →
Alcohol use disorder Indication Strategy Report 2026: GABRA1, Trials and Deals
Latest Hotspot
8 min read
Alcohol use disorder Indication Strategy Report 2026: GABRA1, Trials and Deals
21 July 2026
Alcohol use disorder indication strategy report covering epidemiology, GABRA1 biology, active trials, competition and deal signals using PatSnap MCP evidence.
Read →
Opioid use disorder Indication Strategy Report 2026: μ opioid receptor, Trials and Deals
Latest Hotspot
8 min read
Opioid use disorder Indication Strategy Report 2026: μ opioid receptor, Trials and Deals
21 July 2026
Opioid use disorder indication strategy report covering epidemiology, μ opioid receptor biology, active trials, competition and deal signals using PatSnap MCP...
Read →
Cervical dystonia Indication Strategy Report 2026: SNAP25, Trials and Deals
Latest Hotspot
8 min read
Cervical dystonia Indication Strategy Report 2026: SNAP25, Trials and Deals
21 July 2026
Cervical dystonia indication strategy report covering epidemiology, SNAP25 biology, active trials, competition and deal signals using PatSnap MCP evidence.
Read →